SABA, PIERLUIGI
 Distribuzione geografica
Continente #
EU - Europa 52.332
NA - Nord America 3.084
AS - Asia 339
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 4
AF - Africa 1
Totale 55.765
Nazione #
IT - Italia 51.442
US - Stati Uniti d'America 3.078
SE - Svezia 300
UA - Ucraina 295
CN - Cina 278
DE - Germania 97
GB - Regno Unito 78
FI - Finlandia 66
SG - Singapore 20
FR - Francia 19
IN - India 18
RU - Federazione Russa 12
VN - Vietnam 12
BE - Belgio 9
CA - Canada 6
EU - Europa 5
PL - Polonia 5
NL - Olanda 4
JP - Giappone 3
PT - Portogallo 3
BR - Brasile 2
CL - Cile 2
HK - Hong Kong 2
IR - Iran 2
TR - Turchia 2
CZ - Repubblica Ceca 1
IE - Irlanda 1
KR - Corea 1
MU - Mauritius 1
TW - Taiwan 1
Totale 55.765
Città #
Cagliari 51.266
Woodbridge 383
Fairfield 381
Chandler 336
Houston 267
Ashburn 247
Nyköping 214
Ann Arbor 200
Jacksonville 152
Seattle 150
Dearborn 146
Wilmington 135
Cambridge 128
Nanjing 51
Boardman 47
Boston 41
Shanghai 39
Beijing 34
San Diego 27
Helsinki 23
Santa Maria Coghínas 20
Washington 18
Shenyang 17
Hebei 16
Nanchang 15
Los Angeles 13
Dong Ket 12
Milan 12
Sassari 12
Jinan 11
New York 11
Norwalk 11
Changsha 10
San Mateo 10
Falls Church 9
Redwood City 9
Verona 9
Brussels 8
Auburn Hills 7
Guangzhou 7
Kunming 7
Leawood 7
London 7
Pune 7
Tianjin 7
Hefei 6
Ningbo 6
Orange 6
Saint Petersburg 6
Toronto 6
Jiaxing 5
Mountain View 5
Rome 5
Augusta 4
Bologna 4
Monmouth Junction 4
Alghero 3
Borås 3
Chengdu 3
Fuzhou 3
New Bedfont 3
San Francisco 3
Shenzhen 3
Zhengzhou 3
Amsterdam 2
Ardabil 2
Florence 2
Hangzhou 2
Hong Kong 2
Kilburn 2
Las Vegas 2
Lille 2
Malogoszcz 2
Millbury 2
Montijo 2
Mumbai 2
Nagold 2
Panicale 2
Poznan 2
Sarroch 2
Taizhou 2
Torino 2
Wenzhou 2
Xi'an 2
Xian 2
Boydton 1
Bracke 1
Castiglione Chiavarese 1
Chaoyang 1
Chongqing 1
Coimbatore 1
Cosenza 1
Cracow 1
Dallas 1
Dublin 1
Easton 1
Genoa 1
Gunzenhausen 1
Harbin 1
Hounslow 1
Totale 54.677
Nome #
Selective inhibition of dopamine-beta-hydroxylase enhances dopamine release from noradrenergic terminals in the medial prefrontal cortex 3.220
The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating 2.928
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 2.716
Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation 2.422
Inhibition of 5 alpha-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation 2.338
Noradrenergic terminals are the primary source of α2-adrenoceptor mediated dopamine release in the medial prefrontal cortex 2.308
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.276
Disulfiram stimulates dopamine release from noradrenergic terminals and potentiates cocaine-induced dopamine release in the prefrontal cortex 1.949
null 1.934
6-Hydroxydopamine lesion in the ventral tegmental area fails to reduce extracellular dopamine in the cerebral cortex 1.696
Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus 1.679
The cerebellar GABAA alpha6 subunit is differentially modulated by chronic ethanol exposure in normal (R100R) and mutated (Q100Q) sNP rats 1.466
Isolation rearing-induced reduction of brain 5 alpha-reductase expression: Relevance to dopaminergic impairments 1.422
Synthesis and characterization of NESS 0327: a novel putative antagonist of the CB1 cannabinoid receptor 1.386
Prenatal THC exposure produces a hyperdopaminergic phenotype rescued by pregnenolone 1.350
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex 1.320
Midbrain 6-OHDA lesion fails to reduce extracellular dopamine in cerebral cortex. 1.305
Inhibition of 5-alpha reductase elicits antipsychotic-like effects via post-synaptic mechanisms in nucleus accumbens and prefrontal cortex 1.283
Noradrenergic Source of Dopamine Assessed by Microdialysis in the Medial Prefrontal Cortex 1.231
EFFECT OF NORADRENERGIC DENERVATION ON CEREBRAL CORTEX CATECHOLAMINES IN THE RAT 1.203
Effects of post-weaning social isolation on 5-alpha reductase: Relevance to dopaminergic pathway 1.157
Altered expression level of nucleus accumbens proteins in isolation-reared rats 1.105
Haloperidol, but not clozapine, produces dramatic catalepsy in delta9-THC-treated rats: possible clinical implications 1.081
null 1.078
In vitro evidence for the presence of [3H]-haloperidol uptake in rat brain 831
Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract 823
Effect of the amisulpride isomers on rat catalepsy 712
Prenatal low-level exposure to CO alters postnatal development of hippocampal nitric oxide synthase and haem-oxygenase activities in rats 696
The 5-HT2 antagonist ritanserin blocks dopamine re-uptake in the rat frontal cortex 622
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect 611
Disulfiram and diethylditiocarbamate intoxication affects the storage and release of striatal dopamine 585
Effect of the amisulpride isomers on rat prolactinemia 581
Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing 562
Chronic SCH 23390 produces tolerance to morphine extrapiramidal effects 524
Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants 523
Prenatal exposure to a low concentration of carbon monoxide disrupts hippocampal long-term potentiation in rat offspring 522
null 484
Decreased adenosine A2 receptor function in morphine dependent rats 463
Dithiocarbamate pesticides affect glutamate transport in brain synaptic vesicles 460
null 457
Effect of calcium antagonists on [3H] dopamine uptake 447
Chronic imipramine reduces [3H]SCH 23390 binding and DA sensitive adenylate cyclase in the limbic system 443
null 441
Differential mechanisms in the effects of disulfiram and diethyldithiocarbamate intoxication on striatal release and vesicular transport of glutamate 434
Resistance to extrapyramidal effects of opiates in rats chronically treated with SCH 23390 431
null 423
null 420
Differnatial interaction of 1-methyl-4-phenylpyridinium ion with the putatively vesicular binding site of 3H-tyramine in dopaminergic and non-dopmeinergic brain regions 393
The dopamine beta-hydroxylase inhibitor nepicastat increases dopamine release and potentiates psychostimulant-induced dopamine release in the prefrontal cortex 296
The potent α2-adrenoceptor antagonist RS 79948 also inhibits dopamine D2 -receptors: Comparison with atipamezole and raclopride 220
Prenatal THC Does Not Affect Female Mesolimbic Dopaminergic System in Preadolescent Rats 203
Gating deficits in isolation-reared rats are correlated with alterations in protein expression in nucleus accumbens 172
Combined α2- and D2-receptor blockade activates noradrenergic and dopaminergic neurons, but extracellular dopamine in the prefrontal cortex is determined by uptake and release from noradrenergic terminals 65
Selected pyrethroid insecticides stimulate glutamate uptake in brain synaptic vesicles 61
New benzamide-derived 5-HT3 receptor antagonists which prevent the effects of ethanol on extracellular dopamine, and fail to reduce voluntary alcohol intake in rats 43
Lanthanides stimulate [3H]tyramine binding in the rat striatum 39
Potent, extra-channel influence of several calcium-channel modulators on striatal binding of [3H]tyramine 37
The tyramine-labelled vesicular transporter for dopamine: a putative target of pesticides and neurotoxins 36
Totale 55.913
Categoria #
all - tutte 66.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019777 0 0 0 0 0 0 0 0 0 153 301 323
2019/202015.277 815 455 70 177 5.970 4.167 2.082 436 223 231 271 380
2020/202117.903 469 654 564 5.870 3.924 1.824 1.265 1.058 274 713 770 518
2021/20223.089 348 178 228 227 226 239 204 165 241 286 353 394
2022/20234.135 311 443 419 340 344 421 223 485 301 287 351 210
2023/20243.284 226 186 182 251 395 609 619 317 235 264 0 0
Totale 55.913